• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Comparable hemostatic capacity of blood taken from the portal vein compared with systemic blood in patients with cirrhosis.

作者信息

Blasi Annabel, Calvo Andrea, Mellado Ricard, Torrente Miguel Angel, Turon Fanny, Garcia-Pagan Juan Carlos, Hernandez-Gea Virginia, Tassies Dolors, Reverter Joan Carles, Lisman Ton

机构信息

Anesthesia Department, Hospital Clinic Barcelona, Institut Investigació per a la Recerca Biomèdica Agustí Pi i Sunyé (IDIBAPS), Barcelona, Spain.

Hemostasis Department, Hospital Clinic Barcelona, IDIBAPS, Barcelona, Spain.

出版信息

Res Pract Thromb Haemost. 2024 Oct 9;8(7):102583. doi: 10.1016/j.rpth.2024.102583. eCollection 2024 Oct.

DOI:10.1016/j.rpth.2024.102583
PMID:39552771
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11567948/
Abstract
摘要

相似文献

1
Comparable hemostatic capacity of blood taken from the portal vein compared with systemic blood in patients with cirrhosis.肝硬化患者门静脉血与体循环血相比具有相当的止血能力。
Res Pract Thromb Haemost. 2024 Oct 9;8(7):102583. doi: 10.1016/j.rpth.2024.102583. eCollection 2024 Oct.
2
Predicting portal thrombosis in cirrhosis: A prospective study of clinical, ultrasonographic and hemostatic factors.预测肝硬化门静脉血栓形成：临床、超声和止血因素的前瞻性研究。
J Hepatol. 2021 Dec;75(6):1367-1376. doi: 10.1016/j.jhep.2021.07.020. Epub 2021 Jul 30.
3
AGA Clinical Practice Update: Coagulation in Cirrhosis.AGA 临床实践更新：肝硬化中的凝血。
Gastroenterology. 2019 Jul;157(1):34-43.e1. doi: 10.1053/j.gastro.2019.03.070. Epub 2019 Apr 12.
4
Role of intrahepatic portal-systemic shunts in the reduction of portal blood supply to liver cells in cirrhosis.肝内门体分流在肝硬化时减少肝细胞门静脉血供中的作用。
Am J Gastroenterol. 1988 Jul;83(7):718-22.
5
Portal vein thrombosis in cirrhosis: A literature review.肝硬化门静脉血栓形成：文献综述
Front Med (Lausanne). 2023 Apr 26;10:1134801. doi: 10.3389/fmed.2023.1134801. eCollection 2023.
6
A practical nomogram based on systemic inflammatory markers for predicting portal vein thrombosis in patients with liver cirrhosis.基于全身炎症标志物的实用列线图预测肝硬化患者门静脉血栓形成。
Ann Med. 2022 Dec;54(1):302-309. doi: 10.1080/07853890.2022.2028893.
7
Systemic and pulmonary hemodynamics in patients with extrahepatic portal vein obstruction is similar to compensated cirrhotic patients.肝外门静脉阻塞患者的体循环和肺循环血流动力学与代偿性肝硬化患者相似。
Hepatol Int. 2009 Jun;3(2):384-91. doi: 10.1007/s12072-008-9110-1. Epub 2008 Dec 6.
8
Portal and splenic hemodynamics in cirrhotic patients: relationship between esophageal variceal bleeding and the severity of hepatic failure.肝硬化患者的门静脉和脾血流动力学：食管静脉曲张出血与肝衰竭严重程度之间的关系。
J Gastroenterol. 2004 Jul;39(7):661-7. doi: 10.1007/s00535-003-1362-x.
9
[Portal hemodynamics in patients with different syndromes of cirrhosis].[不同肝硬化综合征患者的门静脉血流动力学]
Zhong Xi Yi Jie He Xue Bao. 2004 May;2(3):178-81. doi: 10.3736/jcim20040307.
10
Clinical characteristics of portal hemodynamics in alcoholic liver cirrhosis.酒精性肝硬化门静脉血流动力学的临床特征
Alcohol Clin Exp Res. 2004 Aug;28(8 Suppl Proceedings):148S-152S. doi: 10.1097/01.alc.0000133550.15109.9e.

引用本文的文献

1
EASL postgraduate course report: Vascular biology in chronic liver disease and clinical management implications.欧洲肝脏研究学会研究生课程报告：慢性肝病中的血管生物学及其临床管理意义
JHEP Rep. 2025 Mar 19;7(8):101399. doi: 10.1016/j.jhepr.2025.101399. eCollection 2025 Aug.

本文引用的文献

1
Anticoagulation improves survival in patients with cirrhosis and portal vein thrombosis: The IMPORTAL competing-risk meta-analysis.抗凝治疗可改善肝硬化合并门静脉血栓形成患者的生存率：IMPORTAL 竞争风险荟萃分析。
J Hepatol. 2023 Jul;79(1):69-78. doi: 10.1016/j.jhep.2023.02.023. Epub 2023 Feb 28.
2
"The portal vein in patients with cirrhosis is not an excessively inflammatory or hypercoagulable vascular bed, a prospective cohort study": comment from Violi et al.“肝硬化患者的门静脉并非炎症过度或高凝的血管床，一项前瞻性队列研究”：来自维奥利等人的评论
J Thromb Haemost. 2023 Jan;21(1):186-187. doi: 10.1016/j.jtha.2022.09.006.
3
Gut dysbiosis, endotoxemia and clotting activation: A dangerous trio for portal vein thrombosis in cirrhosis.肠道菌群失调、内毒素血症与凝血激活：肝硬化门静脉血栓形成的危险三联征
Blood Rev. 2023 Jan;57:100998. doi: 10.1016/j.blre.2022.100998. Epub 2022 Aug 12.
4
The portal vein in patients with cirrhosis is not an excessively inflammatory or hypercoagulable vascular bed, a prospective cohort study.肝硬化患者的门静脉并非炎症过度或高凝的血管床：一项前瞻性队列研究。
J Thromb Haemost. 2022 Sep;20(9):2075-2082. doi: 10.1111/jth.15797. Epub 2022 Jul 11.
5
The Pathophysiology of Portal Vein Thrombosis in Cirrhosis: Getting Deeper into Virchow's Triad.肝硬化门静脉血栓形成的病理生理学：深入探究魏尔啸三要素
J Clin Med. 2022 Feb 2;11(3):800. doi: 10.3390/jcm11030800.
6
Predicting portal thrombosis in cirrhosis: A prospective study of clinical, ultrasonographic and hemostatic factors.预测肝硬化门静脉血栓形成：临床、超声和止血因素的前瞻性研究。
J Hepatol. 2021 Dec;75(6):1367-1376. doi: 10.1016/j.jhep.2021.07.020. Epub 2021 Jul 30.
7
Endothelial Damage of the Portal Vein is Associated with Heparin-Like Effect in Advanced Stages of Cirrhosis.门静脉内皮损伤与肝硬化晚期的肝素样作用有关。
Thromb Haemost. 2020 Aug;120(8):1173-1181. doi: 10.1055/s-0040-1713169. Epub 2020 Jun 30.
8
Plasma levels of circulating DNA are associated with outcome, but not with activation of coagulation in decompensated cirrhosis and ACLF.失代偿期肝硬化和慢加急性肝衰竭患者的循环DNA血浆水平与预后相关，但与凝血激活无关。
JHEP Rep. 2019 Jun 28;1(3):179-187. doi: 10.1016/j.jhepr.2019.06.002. eCollection 2019 Sep.
9
Von Willebrand and Factor VIII Portosystemic Circulation Gradient in Cirrhosis: Implications for Portal Vein Thrombosis.肝硬化中血管性血友病因子与凝血因子VIII的门体循环梯度：对门静脉血栓形成的影响
Clin Transl Gastroenterol. 2020 Feb;11(2):e00123. doi: 10.14309/ctg.0000000000000123.
10
Role of portal venous platelet activation in patients with decompensated cirrhosis and TIPS.门静脉血小板激活在失代偿期肝硬化和经颈静脉肝内门体分流术患者中的作用
Gut. 2020 Aug;69(8):1535-1536. doi: 10.1136/gutjnl-2019-319044. Epub 2019 Jul 3.